BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23002132)

  • 1. Opportunistic screening for familial hypercholesterolaemia via a community laboratory.
    Bell DA; Hooper AJ; Bender R; McMahon J; Edwards G; van Bockxmeer FM; Watts GF; Burnett JR
    Ann Clin Biochem; 2012 Nov; 49(Pt 6):534-7. PubMed ID: 23002132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of various familial hypercholesterolaemia diagnostic criteria compared to Dutch lipid clinic criteria in an Asian population.
    Abdul-Razak S; Rahmat R; Mohd Kasim A; Rahman TA; Muid S; Nasir NM; Ibrahim Z; Kasim S; Ismail Z; Abdul Ghani R; Sanusi AR; Rosman A; Nawawi H
    BMC Cardiovasc Disord; 2017 Oct; 17(1):264. PubMed ID: 29037163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of a collaborative global effort to address the burden of familial hypercholesterolaemia.
    Lyons ARM; Stevens CAT; Dharmayat KI; Vallejo-Vaz DAJ; Ray KK
    Indian Heart J; 2024 Mar; 76 Suppl 1(Suppl 1):S113-S116. PubMed ID: 37981086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis.
    Wald DS; Bestwick JP; Wald NJ
    BMJ; 2007 Sep; 335(7620):599. PubMed ID: 17855284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision screening for familial hypercholesterolaemia: a machine learning study applied to electronic health encounter data.
    Myers KD; Knowles JW; Staszak D; Shapiro MD; Howard W; Yadava M; Zuzick D; Williamson L; Shah NH; Banda JM; Leader J; Cromwell WC; Trautman E; Murray MF; Baum SJ; Myers S; Gidding SS; Wilemon K; Rader DJ
    Lancet Digit Health; 2019 Dec; 1(8):e393-e402. PubMed ID: 33323221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced identification of familial hypercholesterolemia using central laboratory algorithms.
    Ibrahim S; Nurmohamed NS; Nierman MC; de Goeij JN; Zuurbier L; van Rooij J; Schonck WAM; de Vries J; Hovingh GK; Reeskamp LF; Stroes ESG
    Atherosclerosis; 2024 Jun; 393():117548. PubMed ID: 38643673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should Familial Hypercholesterolaemia Be Included in the UK Newborn Whole Genome Sequencing Programme?
    Humphries SE; Ramaswami U; Hopper N
    Curr Atheroscler Rep; 2023 Dec; 25(12):1083-1091. PubMed ID: 38060059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronic health record-based facilitation of familial hypercholesterolaemia detection sensitivity of different algorithms in genetically confirmed patients.
    Mohammadnia N; Akyea RK; Qureshi N; Bax WA; Cornel JH
    Eur Heart J Digit Health; 2022 Dec; 3(4):578-586. PubMed ID: 36710904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected gaps in knowledge of familial hypercholesterolaemia among Dutch general practitioners.
    Ibrahim S; de Goeij JN; Nurmohamed NS; Pang J; van den Bosch SE; Martens FMAC; Roeters van Lennep JE; Corpeleijn W; Tumkaya T; Hovingh GK; Watts GF; Stroes ESG; Reeskamp LF
    Neth Heart J; 2024 May; 32(5):213-220. PubMed ID: 38573436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Health Laboratory Service (NHLS) changes the method of LDL-cholesterol calculation in South Africa.
    Pillay T; Rossouw HM; Steyn N; Carelse A
    S Afr Med J; 2023 Dec; 114(1):16. PubMed ID: 38525620
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of Two Strategies for Hypercholesterolemia Detection through Point-of-Care Testing.
    Arriaga-Cázares HE; Vega-Morales D; Moreno-Treviño CA; Juarez-Juarez JL; Pérez-Arizmendi CA; Martagón-Rosado AJ
    Diagnostics (Basel); 2024 Jan; 14(2):. PubMed ID: 38248020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Testing for Familial Hypercholesterolemia in Clinical Practice.
    Tricou EP; Morgan KM; Betts M; Sturm AC
    Curr Atheroscler Rep; 2023 May; 25(5):197-208. PubMed ID: 37060538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introducing genetic testing with case finding for familial hypercholesterolaemia in primary care: qualitative study of patient and health professional experience.
    Silva L; Condon L; Qureshi N; Dutton B; Weng S; Kai J
    Br J Gen Pract; 2022 Jul; 72(720):e519-e527. PubMed ID: 35697509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for screening for familial hypercholesterolaemia in primary care and other community settings.
    Qureshi N; Da Silva MLR; Abdul-Hamid H; Weng SF; Kai J; Leonardi-Bee J
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD012985. PubMed ID: 34617591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Identification of Familial Hypercholesterolaemia in Primary Care-A Systematic Review.
    Silva L; Qureshi N; Abdul-Hamid H; Weng S; Kai J; Leonardi-Bee J
    J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33920869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial Hypercholesterolemia in Asia Pacific: A Review of Epidemiology, Diagnosis, and Management in the Region.
    Kalra S; Chen Z; Deerochanawong C; Shyu KG; Tan RS; Tomlinson B; Yeh HI
    J Atheroscler Thromb; 2021 May; 28(5):417-434. PubMed ID: 33746137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Hypercholesterolemia: A Narrative Review on Diagnosis and Management Strategies for Children and Adolescents.
    Tada H; Takamura M; Kawashiri MA
    Vasc Health Risk Manag; 2021; 17():59-67. PubMed ID: 33628029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for potential familial hypercholesterolaemia in general practice: an observational study on prevalence and management.
    Mülverstedt S; Hildebrandt PR; Prescott E; Heitmann M
    BJGP Open; 2021 Apr; 5(2):. PubMed ID: 33199307
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.